Evidence map›Paper›PMID 28105204›Full record

ArticleOncology letters2016

Combining fisetin and ionizing radiation suppresses the growth of mammalian colorectal cancers in xenograft tumor models.

Jyh-Der Leu, Bo-Shen Wang, Shu-Jun Chiu, Chun-Yuan Chang, Chien-Chih Chen, Fu-Du Chen, Shiirevnyamba Avirmed, Yi-Jang Lee

Open access · diamondAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Oncology letters, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.2field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Fisetin: An anticancer perspective.Food science & nutrition · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Jyh-Der LeuDepartment of Radiation Oncology, Taipei City Hospital, Renai Branch, Da'an, Taipei 106, Taiwan, R.O.C.
Bo-Shen WangDepartment of Biomedical Imaging and Radiological Sciences, School of Biomedical Engineering, National Yang-Ming University, Beitou, Taipei 112, Taiwan, R.O.C.
Shu-Jun ChiuDepartment of Life Sciences, Tzu Chi University, Hualien 970, Taiwan, R.O.C.
Chun-Yuan ChangDepartment of Biomedical Imaging and Radiological Sciences, School of Biomedical Engineering, National Yang-Ming University, Beitou, Taipei 112, Taiwan, R.O.C.
Chien-Chih ChenDepartment of Family Medicine, Taipei City Hospital, Renai Branch, Da'an, Taipei 112, Taiwan, R.O.C.
Fu-Du ChenDepartment of Electronic Engineering, Hwa-Hsia University of Technology, Zhonghe, Taipei 235, Taiwan, R.O.C.
Shiirevnyamba AvirmedDepartment of Surgery, Mongolian National University of Medical Sciences, Ulaanbaatar 14210, Mongolia.
Yi-Jang LeeDepartment of Biomedical Imaging and Radiological Sciences, School of Biomedical Engineering, National Yang-Ming University, Beitou, Taipei 112, Taiwan, R.O.C.; Biophotonics & Molecular Imaging Research Center, National Yang-Ming University, Beitou, Taipei 112, Taiwan, R.O.C.
Mongolian National University of Medical Sciences · MN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Fisetin (3,7,3',4'-tetrahydroxyflavone), which belongs to the flavonoid group of polyphenols and is found in a wide range of plants, has been reported to exhibit a number of biological activities in human cancer cells, including antioxidant, anti-inflammatory, antiangiogenic, anti-invasive and antiproliferative effects. Although previous

Indexed as

colorectal cancerfisetinradiotherapysecurinxenograft tumor model

Identifiers

PMID28105204
PMCPMC5228362
OpenAlexW2546658567

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.